Submitted by dcc on Mon, 2024-04-15 11:07 Study Title: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk NeuroblastomaCIRB: Cancer Prevention and Control CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
